BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Safety Assessment of Genome Editing in Human Gene Therapy Pr
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-07285-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260714
DTEND;VALUE=DATE:20260715
SUMMARY:FDA comments close: Safety Assessment of Genome Editing in Human G
 ene Therapy Products Using Next-Generation Sequencing\; Draft Guidance fo
 r Industry\; Availability
DESCRIPTION:Notice. Federal Register 2026-07285. Docket FDA-2026-D-1255. D
 etails: https://docket-clock.pages.dev/doc/2026-07285/ Official: https://
 www.federalregister.gov/documents/2026/04/15/2026-07285/safety-assessment
 -of-genome-editing-in-human-gene-therapy-products-using-next-generation-s
 equencing
URL:https://www.federalregister.gov/documents/2026/04/15/2026-07285/safety
 -assessment-of-genome-editing-in-human-gene-therapy-products-using-next-g
 eneration-sequencing
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR